Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
BMC Dev Biol ; 2: 2, 2002.
Article de Anglais | MEDLINE | ID: mdl-11893254

RÉSUMÉ

BACKGROUND: The Rel/NF-kappaB transcription factors have been shown to regulate apoptosis in different cell types, acting as inducers or blockers in a stimuli- and cell type-dependent fashion. One of the Rel/NF-kappaB subunits, RelA, has been shown to be crucial for normal embryonic development, in which it functions in the embryonic liver as a protector against TNFalpha-induced physiological apoptosis. This study assesses whether NF-kappaB may be involved in the embryo's response to teratogens. Fot this, we evaluated how NF-KappaB DNA binding activity in embryonic organs demonstrating differential sensitivity to a reference teratogen, cyclophosphamide, correlates with dysmorphic events induced by the teratogen at the cellular level (excessive apoptosis) and at the organ level (structural anomalies). RESULTS: The embryonic brain and liver were used as target organs. We observed that the Cyclophosphamide-induced excessive apoptosis in the brain, followed by the formation of severe craniofacial structural anomalies, was accompanied by suppression of NF-kappaB DNA-binding activity as well as by a significant and lasting increase in the activity of caspases 3 and 8. However, in the liver, in which cyclophosphamide induced transient apoptosis was not followed by dysmorphogenesis, no suppression of NF-kappaB DNA-binding activity was registered and the level of active caspases 3 and 8 was significantly lower than in the brain. It has also been observed that both the brain and liver became much more sensitive to the CP-induced teratogenic insult if the embryos were exposed to a combined treatment with the teratogen and sodium salicylate that suppressed NF-kappaB DNA-binding activity in these organs. CONCLUSION: The results of this study demonstrate that suppression of NF-kappaB DNA-binding activity in embryos responding to the teratogenic insult may be associated with their decreased resistance to this insult. They also suggest that teratogens may suppress NF-kappaB DNA-binding activity in the embryonic tissues in an organ type- and dose-dependent fashion.


Sujet(s)
Cyclophosphamide/pharmacologie , Protéines de liaison à l'ADN/métabolisme , Embryon de mammifère/effets des médicaments et des substances chimiques , Embryon de mammifère/métabolisme , Facteur de transcription NF-kappa B/métabolisme , Tératogènes/pharmacologie , Malformations multiples/induit chimiquement , Animaux , Apoptose/effets des médicaments et des substances chimiques , Encéphale/effets des médicaments et des substances chimiques , Encéphale/embryologie , Encéphale/métabolisme , Protéines de liaison à l'ADN/antagonistes et inhibiteurs , Embryon de mammifère/malformations , Embryon de mammifère/composition chimique , Femelle , Foie/effets des médicaments et des substances chimiques , Foie/embryologie , Foie/métabolisme , Mâle , Souris , Souris de lignée ICR , Facteur de transcription NF-kappa B/antagonistes et inhibiteurs , Grossesse , Liaison aux protéines/effets des médicaments et des substances chimiques , Salicylate de sodium/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...